B-cell receptor sequencing of anti-citrullinated protein antibody (ACPA) IgG-expressing B cells indicates a selective advantage for the introduction of N-glycosylation sites during somatic hypermutation

Rochelle D. Vergroesen; Linda M. Slot; Lise Hafkenscheid; Marvyn T. Koning; Ellen I. H. van der Voort; Christine A. Grooff; George Zervakis; Hendrik Veelken; Tom W. J. Huizinga; Theo Rispens; Hans U. Scherer; René E. M. Toes

doi:https://doi.org/10.1136/annrheumdis-2017-212052

B-cell receptor sequencing of anti-citrullinated protein antibody (ACPA) IgG-expressing B cells indicates a selective advantage for the introduction of N-glycosylation sites during somatic hypermutation

Rochelle D. Vergroesen, Linda M. Slot, Lise Hafkenscheid, Marvyn T. Koning, Ellen I. H. van der Voort, Christine A. Grooff, George Zervakis, Hendrik Veelken, Tom W. J. Huizinga, Theo Rispens, Hans U. Scherer, René E. M. Toes

Research output: Contribution to journal › Article › Academic › peer-review

55 Citations (Scopus)

Original language	English
Pages (from-to)	956-958
Journal	Annals of the rheumatic diseases
Volume	77
Early online date	2017
DOIs	https://doi.org/10.1136/annrheumdis-2017-212052
Publication status	Published - 2018

Access to Document

https://doi.org/10.1136/annrheumdis-2017-212052

Cite this

Vergroesen, R. D., Slot, L. M., Hafkenscheid, L., Koning, M. T., van der Voort, E. I. H., Grooff, C. A., Zervakis, G., Veelken, H., Huizinga, T. W. J., Rispens, T., Scherer, H. U., & Toes, R. E. M. (2018). B-cell receptor sequencing of anti-citrullinated protein antibody (ACPA) IgG-expressing B cells indicates a selective advantage for the introduction of N-glycosylation sites during somatic hypermutation. Annals of the rheumatic diseases, 77, 956-958. https://doi.org/10.1136/annrheumdis-2017-212052

@article{6dd45d20c2294655a0d6fc01cf287c8a,

title = "B-cell receptor sequencing of anti-citrullinated protein antibody (ACPA) IgG-expressing B cells indicates a selective advantage for the introduction of N-glycosylation sites during somatic hypermutation",

author = "Vergroesen, {Rochelle D.} and Slot, {Linda M.} and Lise Hafkenscheid and Koning, {Marvyn T.} and {van der Voort}, {Ellen I. H.} and Grooff, {Christine A.} and George Zervakis and Hendrik Veelken and Huizinga, {Tom W. J.} and Theo Rispens and Scherer, {Hans U.} and Toes, {Ren{\'e} E. M.}",

year = "2018",

doi = "https://doi.org/10.1136/annrheumdis-2017-212052",

language = "English",

volume = "77",

pages = "956--958",

journal = "Annals of the rheumatic diseases",

issn = "0003-4967",

publisher = "BMJ Publishing Group",

}

Vergroesen, RD, Slot, LM, Hafkenscheid, L, Koning, MT, van der Voort, EIH, Grooff, CA, Zervakis, G, Veelken, H, Huizinga, TWJ, Rispens, T, Scherer, HU & Toes, REM 2018, 'B-cell receptor sequencing of anti-citrullinated protein antibody (ACPA) IgG-expressing B cells indicates a selective advantage for the introduction of N-glycosylation sites during somatic hypermutation', Annals of the rheumatic diseases, vol. 77, pp. 956-958. https://doi.org/10.1136/annrheumdis-2017-212052

B-cell receptor sequencing of anti-citrullinated protein antibody (ACPA) IgG-expressing B cells indicates a selective advantage for the introduction of N-glycosylation sites during somatic hypermutation. / Vergroesen, Rochelle D.; Slot, Linda M.; Hafkenscheid, Lise et al.
In: Annals of the rheumatic diseases, Vol. 77, 2018, p. 956-958.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - B-cell receptor sequencing of anti-citrullinated protein antibody (ACPA) IgG-expressing B cells indicates a selective advantage for the introduction of N-glycosylation sites during somatic hypermutation

AU - Vergroesen, Rochelle D.

AU - Slot, Linda M.

AU - Hafkenscheid, Lise

AU - Koning, Marvyn T.

AU - van der Voort, Ellen I. H.

AU - Grooff, Christine A.

AU - Zervakis, George

AU - Veelken, Hendrik

AU - Huizinga, Tom W. J.

AU - Rispens, Theo

AU - Scherer, Hans U.

AU - Toes, René E. M.

PY - 2018

Y1 - 2018

U2 - https://doi.org/10.1136/annrheumdis-2017-212052

DO - https://doi.org/10.1136/annrheumdis-2017-212052

M3 - Article

C2 - 28835463

SN - 0003-4967

VL - 77

SP - 956

EP - 958

JO - Annals of the rheumatic diseases

JF - Annals of the rheumatic diseases

ER -

Vergroesen RD, Slot LM, Hafkenscheid L, Koning MT, van der Voort EIH, Grooff CA et al. B-cell receptor sequencing of anti-citrullinated protein antibody (ACPA) IgG-expressing B cells indicates a selective advantage for the introduction of N-glycosylation sites during somatic hypermutation. Annals of the rheumatic diseases. 2018;77:956-958. Epub 2017. doi: https://doi.org/10.1136/annrheumdis-2017-212052